InsidersTradesSigma
Follow the Oxford Immunotec Global PLC stock price and the full management transaction log of the company, a listed equity based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Market capitalisation: €129.1m. The latest transaction was disclosed on 19 January 2016 (Levée d'options). Among the most active insiders: RANDALL PATRICIA. Every trade is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Oxford Immunotec Global PLC is a company focused on developing diagnostic tests for infectious diseases, particularly tuberculosis. It is listed on NASDAQ under the ticker OXFD.